Viveve Medical, Inc. (VIVE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2021 | 10.84 Million USD | 12.33% |
| 2020 | 9.65 Million USD | -7.65% |
| 2019 | 10.45 Million USD | -75.06% |
| 2018 | 41.92 Million USD | 8.38% |
| 2017 | 38.67 Million USD | 158.65% |
| 2016 | 14.95 Million USD | 97.86% |
| 2015 | 7.55 Million USD | 140.78% |
| 2014 | 3.13 Million USD | -61.72% |
| 2013 | 8.2 Million USD | -37.11% |
| 2012 | 13.03 Million USD | 70.72% |
| 2011 | 7.63 Million USD | 306.01% |
| 2010 | 1.88 Million USD | -43.22% |
| 2009 | 3.31 Million USD | -29.84% |
| 2008 | 4.72 Million USD | -24.45% |
| 2007 | 6.25 Million USD | 3.36% |
| 2006 | 6.04 Million USD | -12.67% |
| 2005 | 6.92 Million USD | 6.56% |
| 2004 | 6.49 Million USD | 183.38% |
| 2003 | 2.29 Million USD | -36.36% |
| 2002 | 3.6 Million USD | -39.83% |
| 2001 | 5.98 Million USD | -32.43% |
| 2000 | 8.86 Million USD | 37.74% |
| 1999 | 6.43 Million USD | 14.89% |
| 1998 | 5.6 Million USD | -30.0% |
| 1997 | 8 Million USD | 175.86% |
| 1996 | 2.9 Million USD | 3.57% |
| 1995 | 2.8 Million USD | 133.33% |
| 1994 | 1.2 Million USD | 33.33% |
| 1993 | 900 Thousand USD | -35.71% |
| 1992 | 1.4 Million USD | 7.69% |
| 1991 | 1.3 Million USD | 0.0% |
| 1990 | - USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 Q1 | 10.52 Million USD | -2.94% |
| 2022 Q3 | 10.97 Million USD | 7.41% |
| 2022 Q2 | 10.21 Million USD | -2.99% |
| 2021 Q4 | 10.84 Million USD | 8.26% |
| 2021 FY | 10.84 Million USD | 12.33% |
| 2021 Q1 | 10.13 Million USD | 4.91% |
| 2021 Q2 | 8.91 Million USD | -12.01% |
| 2021 Q3 | 10.01 Million USD | 12.41% |
| 2020 Q1 | 8.88 Million USD | -15.06% |
| 2020 Q3 | 8.83 Million USD | -10.78% |
| 2020 Q2 | 9.9 Million USD | 11.53% |
| 2020 FY | 9.65 Million USD | -7.65% |
| 2020 Q4 | 9.65 Million USD | 9.27% |
| 2019 Q1 | 39.43 Million USD | -5.93% |
| 2019 Q4 | 10.45 Million USD | -73.15% |
| 2019 FY | 10.45 Million USD | -75.06% |
| 2019 Q2 | 39.16 Million USD | -0.69% |
| 2019 Q3 | 38.93 Million USD | -0.58% |
| 2018 Q2 | 40.15 Million USD | 6.58% |
| 2018 Q1 | 37.67 Million USD | -2.6% |
| 2018 FY | 41.92 Million USD | 8.38% |
| 2018 Q4 | 41.92 Million USD | 6.93% |
| 2018 Q3 | 39.2 Million USD | -2.36% |
| 2017 Q1 | 15.2 Million USD | 1.65% |
| 2017 FY | 38.67 Million USD | 158.65% |
| 2017 Q4 | 38.67 Million USD | 47.38% |
| 2017 Q3 | 26.24 Million USD | 9.73% |
| 2017 Q2 | 23.91 Million USD | 57.35% |
| 2016 Q1 | 8.22 Million USD | 8.88% |
| 2016 Q2 | 13.5 Million USD | 64.1% |
| 2016 Q3 | 14.05 Million USD | 4.04% |
| 2016 Q4 | 14.95 Million USD | 6.43% |
| 2016 FY | 14.95 Million USD | 97.86% |
| 2015 Q3 | 6.92 Million USD | 23.63% |
| 2015 FY | 7.55 Million USD | 140.78% |
| 2015 Q1 | 4.69 Million USD | 49.57% |
| 2015 Q4 | 7.55 Million USD | 9.09% |
| 2015 Q2 | 5.6 Million USD | 19.36% |
| 2014 Q4 | 3.13 Million USD | 29.42% |
| 2014 Q3 | 2.42 Million USD | -62.69% |
| 2014 Q2 | 6.5 Million USD | -32.43% |
| 2014 Q1 | 9.62 Million USD | 17.32% |
| 2014 FY | 3.13 Million USD | -61.72% |
| 2013 Q1 | 22.87 Million USD | 75.45% |
| 2013 Q3 | 13.07 Million USD | 8.86% |
| 2013 Q2 | 12 Million USD | -47.5% |
| 2013 FY | 8.2 Million USD | -37.11% |
| 2013 Q4 | 8.2 Million USD | -37.28% |
| 2012 Q1 | 13.21 Million USD | 73.05% |
| 2012 Q4 | 13.03 Million USD | -22.62% |
| 2012 Q3 | 16.85 Million USD | 21.52% |
| 2012 Q2 | 13.86 Million USD | 4.92% |
| 2012 FY | 13.03 Million USD | 70.72% |
| 2011 FY | 7.63 Million USD | 306.01% |
| 2011 Q4 | 7.63 Million USD | 6.17% |
| 2011 Q3 | 7.19 Million USD | -7.02% |
| 2011 Q2 | 7.73 Million USD | -7.16% |
| 2011 Q1 | 8.33 Million USD | 343.01% |
| 2010 Q4 | 1.88 Million USD | -15.57% |
| 2010 Q1 | 2.99 Million USD | -9.6% |
| 2010 FY | 1.88 Million USD | -43.22% |
| 2010 Q2 | 2.71 Million USD | -9.28% |
| 2010 Q3 | 2.22 Million USD | -18.0% |
| 2009 FY | 3.31 Million USD | -29.84% |
| 2009 Q1 | 3.86 Million USD | -18.21% |
| 2009 Q2 | 3.69 Million USD | -4.27% |
| 2009 Q3 | 3.62 Million USD | -2.03% |
| 2009 Q4 | 3.31 Million USD | -8.53% |
| 2008 Q1 | 6.05 Million USD | -3.1% |
| 2008 Q2 | 5.16 Million USD | -14.68% |
| 2008 Q4 | 4.72 Million USD | -7.85% |
| 2008 FY | 4.72 Million USD | -24.45% |
| 2008 Q3 | 5.12 Million USD | -0.83% |
| 2007 FY | 6.25 Million USD | 3.36% |
| 2007 Q2 | 5.82 Million USD | -3.39% |
| 2007 Q4 | 6.25 Million USD | 0.22% |
| 2007 Q3 | 6.23 Million USD | 7.11% |
| 2007 Q1 | 6.02 Million USD | -0.35% |
| 2006 Q2 | 6.72 Million USD | 0.45% |
| 2006 Q1 | 6.69 Million USD | -3.37% |
| 2006 FY | 6.04 Million USD | -12.67% |
| 2006 Q4 | 6.04 Million USD | -7.06% |
| 2006 Q3 | 6.5 Million USD | -3.2% |
| 2005 Q1 | 6.89 Million USD | 6.09% |
| 2005 Q4 | 6.92 Million USD | -1.87% |
| 2005 Q2 | 7.04 Million USD | 2.16% |
| 2005 FY | 6.92 Million USD | 6.56% |
| 2005 Q3 | 7.05 Million USD | 0.18% |
| 2004 Q3 | 6.78 Million USD | -1.27% |
| 2004 FY | 6.49 Million USD | 183.38% |
| 2004 Q1 | 7.27 Million USD | 217.18% |
| 2004 Q2 | 6.87 Million USD | -5.46% |
| 2004 Q4 | 6.49 Million USD | -4.29% |
| 2003 FY | 2.29 Million USD | -36.36% |
| 2003 Q4 | 2.29 Million USD | -19.74% |
| 2003 Q3 | 2.85 Million USD | -18.02% |
| 2003 Q2 | 3.48 Million USD | 3.72% |
| 2003 Q1 | 3.36 Million USD | -6.74% |
| 2002 Q2 | 4.71 Million USD | -3.36% |
| 2002 Q1 | 4.87 Million USD | -18.55% |
| 2002 FY | 3.6 Million USD | -39.83% |
| 2002 Q4 | 3.6 Million USD | -21.57% |
| 2002 Q3 | 4.59 Million USD | -2.52% |
| 2001 Q3 | 6.73 Million USD | -6.34% |
| 2001 Q2 | 7.19 Million USD | -4.28% |
| 2001 Q1 | 7.51 Million USD | -15.18% |
| 2001 FY | 5.98 Million USD | -32.43% |
| 2001 Q4 | 5.98 Million USD | -11.14% |
| 2000 Q4 | 8.86 Million USD | 10.1% |
| 2000 Q2 | 7.57 Million USD | 10.7% |
| 2000 Q1 | 6.84 Million USD | 6.33% |
| 2000 FY | 8.86 Million USD | 37.74% |
| 2000 Q3 | 8.04 Million USD | 6.29% |
| 1999 Q3 | 5.8 Million USD | -4.92% |
| 1999 FY | 6.43 Million USD | 14.89% |
| 1999 Q1 | 5.5 Million USD | -1.79% |
| 1999 Q2 | 6.1 Million USD | 10.91% |
| 1999 Q4 | 6.43 Million USD | 10.93% |
| 1998 Q2 | 9.9 Million USD | 110.64% |
| 1998 Q4 | 5.6 Million USD | -34.88% |
| 1998 Q3 | 8.6 Million USD | -13.13% |
| 1998 Q1 | 4.7 Million USD | -41.25% |
| 1998 FY | 5.6 Million USD | -30.0% |
| 1997 Q2 | 3.7 Million USD | 32.14% |
| 1997 Q3 | 7.3 Million USD | 97.3% |
| 1997 Q4 | 8 Million USD | 9.59% |
| 1997 FY | 8 Million USD | 175.86% |
| 1997 Q1 | 2.8 Million USD | -3.45% |
| 1996 Q2 | 3.2 Million USD | 0.0% |
| 1996 Q3 | 3 Million USD | -6.25% |
| 1996 Q4 | 2.9 Million USD | -3.33% |
| 1996 FY | 2.9 Million USD | 3.57% |
| 1996 Q1 | 3.2 Million USD | 14.29% |
| 1995 FY | 2.8 Million USD | 133.33% |
| 1995 Q4 | 2.8 Million USD | 0.0% |
| 1994 Q2 | 1.3 Million USD | 62.5% |
| 1994 Q3 | 1 Million USD | -23.08% |
| 1994 FY | 1.2 Million USD | 33.33% |
| 1994 Q4 | 1.2 Million USD | 20.0% |
| 1994 Q1 | 800 Thousand USD | -11.11% |
| 1993 Q2 | 1.5 Million USD | 15.38% |
| 1993 Q4 | 900 Thousand USD | -35.71% |
| 1993 Q3 | 1.4 Million USD | -6.67% |
| 1993 FY | 900 Thousand USD | -35.71% |
| 1993 Q1 | 1.3 Million USD | -7.14% |
| 1992 FY | 1.4 Million USD | 7.69% |
| 1992 Q3 | 2.5 Million USD | 4.17% |
| 1992 Q4 | 1.4 Million USD | -44.0% |
| 1992 Q2 | 2.4 Million USD | 20.0% |
| 1992 Q1 | 2 Million USD | 53.85% |
| 1991 FY | 1.3 Million USD | 0.0% |
| 1991 Q4 | 1.3 Million USD | 0.0% |
| 1990 FY | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 78.837% |
| BrainsWay Ltd. | 15.31 Million USD | 29.169% |
| Cerus Corporation | 144.3 Million USD | 92.483% |
| Envoy Medical, Inc. | 9.4 Million USD | -15.369% |
| electroCore, Inc. | 8.94 Million USD | -21.263% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -103.051% |
| IceCure Medical Ltd | 4.24 Million USD | -155.404% |
| Inogen, Inc. | 121.38 Million USD | 91.064% |
| OrthoPediatrics Corp. | 72.56 Million USD | 85.051% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 63.331% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -240.892% |
| MaxCyte, Inc. | 36.1 Million USD | 69.959% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -486.987% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -2450.549% |
| Orthofix Medical Inc. | 326.58 Million USD | 96.679% |
| PAVmed Inc | 57.13 Million USD | 81.016% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 57.401% |
| RxSight, Inc. | 22.18 Million USD | 51.113% |
| Sight Sciences, Inc. | 46.43 Million USD | 76.641% |
| SI-BONE, Inc. | 61.05 Million USD | 82.233% |
| TELA Bio, Inc. | 59.16 Million USD | 81.667% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 90.482% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -5.117% |
| Acutus Medical, Inc. | 54.83 Million USD | 80.22% |
| Talis Biomedical Corporation | 29.22 Million USD | 62.883% |
| Spectral AI, Inc. | 12.4 Million USD | 12.531% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 53.112% |
| CVRx, Inc. | 39.28 Million USD | 72.387% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | 9.291% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -346.507% |
| Bioventus Inc. | 589.79 Million USD | 98.161% |
| Venus Concept Inc. | 107.1 Million USD | 89.872% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 79.004% |
| LivaNova PLC | 1.15 Billion USD | 99.058% |
| 908 Devices Inc. | 37.49 Million USD | 71.067% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 98.458% |
| Nemaura Medical Inc. | 26.37 Million USD | 58.878% |
| NeuroPace, Inc. | 86.99 Million USD | 87.532% |
| LENSAR, Inc. | 22.4 Million USD | 51.595% |
| Apyx Medical Corporation | 52.31 Million USD | 79.267% |
| Cutera, Inc. | 518.12 Million USD | 97.906% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 63.015% |
| BioSig Technologies, Inc. | 4.68 Million USD | -131.526% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 81.416% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 49.521% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.506% |
| Axonics, Inc. | 82.35 Million USD | 86.83% |
| Outset Medical, Inc. | 190.91 Million USD | 94.318% |
| IRIDEX Corporation | 24.91 Million USD | 56.462% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 91.25% |
| IRadimed Corporation | 20.73 Million USD | 47.69% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -547.969% |
| INVO Bioscience, Inc. | 19.99 Million USD | 45.751% |
| Telesis Bio, Inc. | 40.87 Million USD | 73.462% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 73.408% |
| Varex Imaging Corporation | 668.6 Million USD | 98.378% |
| Quipt Home Medical Corp. | 136.29 Million USD | 92.041% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -203.667% |
| Pulmonx Corporation | 60.63 Million USD | 82.111% |
| Dynatronics Corporation | 11.78 Million USD | 7.921% |
| Modular Medical, Inc. | 2.27 Million USD | -377.421% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -166.905% |
| Semler Scientific, Inc. | 6.27 Million USD | -72.998% |
| InMode Ltd. | 75.91 Million USD | 85.711% |
| Bruker Corporation | 2.83 Billion USD | 99.618% |
| Cytosorbents Corporation | 29.98 Million USD | 63.826% |
| DexCom, Inc. | 4.19 Billion USD | 99.741% |
| Align Technology, Inc. | 2.45 Billion USD | 99.558% |
| ZimVie Inc. | 795.85 Million USD | 98.637% |
| Movano Inc. | 5.97 Million USD | -81.631% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 89.631% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -2450.549% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 9.291% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 98.303% |
| Profound Medical Corp. | 12.66 Million USD | 14.36% |
| Insulet Corporation | 1.85 Billion USD | 99.415% |
| enVVeno Medical Corporation | 2.43 Million USD | -345.462% |
| Surmodics, Inc. | 65.82 Million USD | 83.521% |
| iCAD, Inc. | 8 Million USD | -35.571% |
| Nuwellis, Inc. | 6.78 Million USD | -59.985% |
| Biotricity, Inc. | 35.91 Million USD | 69.802% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 95.137% |
| Aethlon Medical, Inc. | 2.47 Million USD | -337.441% |
| InspireMD, Inc. | 8.14 Million USD | -33.223% |
| PAVmed Inc. | 57.13 Million USD | 81.016% |
| BIOLASE, Inc. | 35.34 Million USD | 69.314% |
| Beyond Air, Inc. | 29.77 Million USD | 63.57% |
| FONAR Corporation | 57.45 Million USD | 81.122% |
| AxoGen, Inc. | 101.16 Million USD | 89.278% |
| Vivani Medical, Inc. | 25.03 Million USD | 56.674% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 87.645% |
| Inari Medical, Inc. | 209.32 Million USD | 94.818% |
| UFP Technologies, Inc. | 118.04 Million USD | 90.811% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | 14.527% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -396.246% |
| Tenon Medical, Inc. | 5.56 Million USD | -94.845% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -509.725% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 38.489% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.656% |
| Sintx Technologies, Inc. | 6.59 Million USD | -64.523% |
| NanoVibronix, Inc. | 2.68 Million USD | -303.835% |
| Quanterix Corporation | 78.08 Million USD | 86.109% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -203.667% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -122.047% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 98.962% |
| TransMedics Group, Inc. | 568.84 Million USD | 98.093% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 34.978% |
| NeuroMetrix, Inc. | 1.33 Million USD | -713.653% |
| Hyperfine, Inc. | 9.8 Million USD | -10.684% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 95.665% |
| Biomerica, Inc. | 2.66 Million USD | -307.323% |
| Bone Biologics Corporation | 831.4 Thousand USD | -1204.664% |
| AVITA Medical, Inc. | 19.86 Million USD | 45.398% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -449.582% |
| Silk Road Medical, Inc | 114.15 Million USD | 90.498% |